Neoisoliquiritin

Neoisoliquiritin Struktur
59122-93-9
CAS-Nr.
59122-93-9
Englisch Name:
Neoisoliquiritin
Synonyma:
isoneoliquiritin;4'-Glucosylisoliquiritigenin;4'-Glucosyl-iso-liquiritigenin;(E)-2',4-Dihydroxy-4'-(β-D-glucopyranosyloxy)chalcone;2-Propen-1-one, 1-[4-(β-D-glucopyranosyloxy)-2-hydroxyphenyl]-3-(4-hydroxyphenyl)-, (2E)-
CBNumber:
CB72375976
Summenformel:
C21H22O9
Molgewicht:
418.39
MOL-Datei:
59122-93-9.mol

Neoisoliquiritin Eigenschaften

Schmelzpunkt:
187-189 °C
Siedepunkt:
745.9±60.0 °C(Predicted)
Dichte
1.528±0.06 g/cm3(Predicted)
pka
7.19±0.35(Predicted)

Sicherheit

Neoisoliquiritin Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

neoisoliquiritin inhibits tumor progression by targeting GRP78-β-catenin signaling in human breast cancer cell xenograft mouse model. A cancer chemopreventive agent.

Neoisoliquiritin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Neoisoliquiritin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 31)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Chengdu Biopurify Phytochemicals Ltd.
+8618080483897
sales@biopurify.com China 3772 58
Wuhan ChemNorm Biotech Co.,Ltd.
+86-27-8439 4403 18971486879
sales@chemnorm.com CHINA 2935 58
ANHUI WITOP BIOTECH CO., LTD
+8615255079626
eric@witopchemical.com China 23541 58
Hangzhou Huarong Pharm Co., Ltd.
571-86758373 +8613588754946
sales@huarongpharm.com CHINA 3148 58
TargetMol Chemicals Inc.

support@targetmol.com United States 38631 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 52924 58
Shanghai Winherb Medical Technology Co., Ltd. 400-186-5138 13341702378
winherb@126.com China 1008 58
Wuhan ChemFaces Biochemical Co., Ltd. 18607101326 15172504745
aileen@chemfaces.com China 7057 55
Chengdu Push Bio-Technology Co., Ltd. 028-85370565-229 18080489829
3004654993@qq.com China 8861 60
Nanjing Digger Medical Technology Co. Ltd. 025-025-51191215 18013836722
2399235533@qq.com China 4933 58
Copyright 2019 © ChemicalBook. All rights reserved